Catherine Ramsey
Stock Analyst at Baird
(3.29)
# 1,038
Out of 5,024 analysts
51
Total ratings
41.03%
Success rate
7.03%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ILMN Illumina | Maintains: Neutral | $84 → $105 | $93.00 | +12.90% | 6 | Jul 28, 2025 | |
WAT Waters | Maintains: Outperform | $374 → $352 | $332.41 | +5.89% | 11 | Jul 16, 2025 | |
TWST Twist Bioscience | Maintains: Outperform | $54 → $44 | $32.04 | +37.33% | 7 | May 6, 2025 | |
RVTY Revvity | Maintains: Outperform | $127 → $125 | $92.12 | +35.69% | 5 | Apr 29, 2025 | |
NTRA Natera | Maintains: Outperform | $183 → $188 | $179.42 | +4.78% | 6 | Feb 28, 2025 | |
CSTL Castle Biosciences | Maintains: Outperform | $36 → $37 | $22.51 | +64.37% | 8 | Feb 28, 2025 | |
TMO Thermo Fisher Scientific | Maintains: Outperform | $695 → $665 | $527.87 | +25.98% | 2 | Nov 1, 2022 | |
A Agilent Technologies | Maintains: Outperform | $155 → $160 | $139.65 | +14.57% | 5 | Aug 17, 2022 | |
EXAS Exact Sciences | Maintains: Outperform | $90 → $75 | $60.58 | +23.80% | 1 | Aug 3, 2022 |
Illumina
Jul 28, 2025
Maintains: Neutral
Price Target: $84 → $105
Current: $93.00
Upside: +12.90%
Waters
Jul 16, 2025
Maintains: Outperform
Price Target: $374 → $352
Current: $332.41
Upside: +5.89%
Twist Bioscience
May 6, 2025
Maintains: Outperform
Price Target: $54 → $44
Current: $32.04
Upside: +37.33%
Revvity
Apr 29, 2025
Maintains: Outperform
Price Target: $127 → $125
Current: $92.12
Upside: +35.69%
Natera
Feb 28, 2025
Maintains: Outperform
Price Target: $183 → $188
Current: $179.42
Upside: +4.78%
Castle Biosciences
Feb 28, 2025
Maintains: Outperform
Price Target: $36 → $37
Current: $22.51
Upside: +64.37%
Thermo Fisher Scientific
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $527.87
Upside: +25.98%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $139.65
Upside: +14.57%
Exact Sciences
Aug 3, 2022
Maintains: Outperform
Price Target: $90 → $75
Current: $60.58
Upside: +23.80%